These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative microscopic study on response of Ehrlich carcinoma to BNCT vs. chemo- and radiotherapy. Samarrai SF; al-Mufti AW; Hikmat S; Karim JM; al-Hayani R; Sugano H; Saito T; Tsukagoshi S; Amano K; Hatanaka H Strahlenther Onkol; 1989; 165(2-3):217-8. PubMed ID: 2494734 [No Abstract] [Full Text] [Related]
4. Biological efficacy of a boronated porphyrin as measured in cell culture. Laster BH; Kahl SB; Kalef-Ezra J; Popenoe EA; Fairchild RG Strahlenther Onkol; 1989; 165(2-3):203-5. PubMed ID: 2494728 [No Abstract] [Full Text] [Related]
5. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia. Tamat SR; Patwardhan A; Moore DE; Kabral A; Bradstock K; Hersey P; Allen BJ Strahlenther Onkol; 1989; 165(2-3):145-7. PubMed ID: 2494717 [No Abstract] [Full Text] [Related]
6. Boron determination for neutron capture therapy by colorimetry and emission spectrometry. Strouf O; Mertenová E; Schneiderová L; Zámecníková H; Janků I Strahlenther Onkol; 1989; 165(2-3):174-6. PubMed ID: 2494723 [No Abstract] [Full Text] [Related]
7. Enhanced survival in a rat glioma model following BNCT. Clendenon NR; Barth RF; Goodman JH; Staubus AE; Gordon WA; Moeschberger ML; Alam F; Soloway AH; Fairchild RG; Slatkin DN Strahlenther Onkol; 1989; 165(2-3):222-5. PubMed ID: 2494736 [No Abstract] [Full Text] [Related]
8. Canine spontaneous brain tumors--a large animal model for BNCT. Gavin PR; Kraft SL; Wendling LR; Miller DL Strahlenther Onkol; 1989; 165(2-3):225-8. PubMed ID: 2494737 [No Abstract] [Full Text] [Related]
9. Perspectives of the clinical BNCT of malignant gliomas in Czechoslovakia. Sourek K; Tovarys F Strahlenther Onkol; 1989; 165(2-3):247-9. PubMed ID: 2494741 [No Abstract] [Full Text] [Related]
10. RBE of thermal neutron capture therapy using 10B1-para-boronophenylalanine for human and B-16 melanoma cells. Ichihashi M; Sasase A; Hiramoto T; Mishima Y; Fukuda H; Kobayashi T Strahlenther Onkol; 1989; 165(2-3):198-201. PubMed ID: 2494727 [No Abstract] [Full Text] [Related]
11. The incorporation of boronated substances into melanin in vitro--an experimental model for melanotic melanoma. Roberto A; Larsson BS Strahlenther Onkol; 1989; 165(2-3):165-7. PubMed ID: 2494722 [No Abstract] [Full Text] [Related]
12. Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy. Mill AJ Strahlenther Onkol; 1989; 165(2-3):193-6. PubMed ID: 2494726 [No Abstract] [Full Text] [Related]
13. [RBEs of thermal neutron capture therapy and 10B(n, alpha)7Li reaction on melanoma bearing hamster]. Hiratsuka J; Kono M; Mishima Y Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Jun; 48(6):759-66. PubMed ID: 3217252 [No Abstract] [Full Text] [Related]
14. [Kinetics of the cell population of transplantable murine B-16 melanoma after administration of mercaptoundecahydrododecaborate enriched with 10B]. Shabalkin IP; Spryshkova RA; Serebriakov NG Med Radiol (Mosk); 1985 Nov; 30(11):32-4. PubMed ID: 4068942 [TBL] [Abstract][Full Text] [Related]
15. Fast neutrons from the Essen cyclotron can be used successfully for neutron capture experiments in vitro. Ziegler W; Sauerwein W; Streffer C Strahlenther Onkol; 1989; 165(2-3):210-2. PubMed ID: 2494731 [No Abstract] [Full Text] [Related]
16. Distributions of sulfhydryl borane monomer and dimer in rodents and monomer in humans: boron neutron capture therapy of melanoma and glioma in boronated rodents. Slatkin DN; Joel DD; Fairchild RG; Micca PL; Nawrocky MM; Laster BH; Coderre JA; Finkel GC; Poletti CE; Sweet WH Basic Life Sci; 1989; 50():179-91. PubMed ID: 2751607 [No Abstract] [Full Text] [Related]
17. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model. Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113 [TBL] [Abstract][Full Text] [Related]
18. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618 [TBL] [Abstract][Full Text] [Related]